23
2014
-
06
"Multi-center randomized double-blind controlled study of Huaier granules for follow-up treatment of triple-negative breast cancer" program seminar held in Chongqing
Breast cancer is one of the most common malignant tumors in women. In the incidence of female malignant tumors in my country, breast cancer ranks first, and the mortality rate ranks fourth. It is a major disease that seriously threatens women's health and life.
Triple-negative breast cancer is an independent clinical pathological type, accounting for 25%-30% of all breast cancer cases. This kind of tumor has strong infiltration, high recurrence rate and poor prognosis. Neither endocrine therapy nor biological targeted therapy can be carried out. Therefore, the lack of effective follow-up treatment for triple negative breast cancer after regular comprehensive treatment has become one of the difficulties in the clinical treatment of breast cancer.
Existing studies have shown that Huaier particles have the effects of enhancing immune function, promoting apoptosis of tumor cells, anti-angiogenesis, reversing drug resistance of tumor cells and inhibiting the invasion of highly metastatic tumor cells. Therefore, Huaier Granule may become an effective supplementary drug for triple negative breast cancer after comprehensive treatment, so as to improve the prognosis and quality of life of patients with triple negative breast cancer.
A few days ago, Professor Jiang Jun, Department of Breast Surgery, Southwest Hospital of the Third Military Medical University, led the organization and joined experts in related fields to discuss this plan for the first time. According to the opinions of the seminar, improve the plan as soon as possible and strive for an early start.
More news
Address
1166 West Nanyuan Road, Qidong Economic Development Zone, Jiangsu Province
Telephone
Mobile website
Public Number
Copyright © 2024 Qidong Gaitianli Pharmaceutical Co., Ltd.